维普中文期刊产品整合服务
31篇 您的检索式:作者名="Zsiros"
    题名 作者 年代 出处 被引量
1Postnatal NMDA receptor ablation in corticolimnic interneurions confers shizophrenia-like phenotypes显示文摘Belforte J Zsiros V Skalar E R 2010Nat Neurosci2010,13,1:1
2Immunotherapy for ovarian cancer: recent advances and perspectives显示文摘Zsiros E Tanyi J Balint K 2014Curr Opin Oncol2014,26,5:1
3Dose-dense cisplatin-based chemotherapy and surgery for children with high risk hepatoblasto- ma (SIOPEL 4): a prospective, single-ann, feasibility study 显示文摘Zsiros J Brugieres L Brock P 2013LancetOncol2013,14,9:1
4Efficacy ofirinotecan single drug treatment in children with refractory or recurrent hepatoblas- toma-a phase II trial of the childhood liver turnout strategy group (SIOPEL) 显示文摘Zsiros J Brugieres L Brock P 2012Eur J Cancer2012,48,18:1
5Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and and surgery: Final result of the SIOPEL-3HR study显示文摘Zsiros J Maibach R Schafford E 2010J Clin Oncol2010,28,15:1
6GABAergic intemeu-ron origin of schizophrenia pathophysiology显示文摘Nakazawa K Zsiros V Jiang Z 2012Neurophar-macology2012,62,3:1
7The combination of intrave-nous bevacizumab and metronomic oral cyclophosphamide is an ef-fective regimen for platinum-resistant recurrent ovarian cancer显示文摘Barber EL Zsiros E Lurain JR 2013J Gynecol Oncol2013,24,3:1
8The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer显示文摘Barber EL Zsiros E Lurain JR 2013J Gynecol Oncol2013,24,3:1
9Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience显示文摘Maretta De Ioris Laurence Brugieres Arthur Zimmermann Jean Keeling Penelope Brock Rudolf Maibach Jon Pritchard Liz Shafford Joszef Zsiros Piotr Czaudzerna Giorgio Perilongo European Journal of Cancer0,,:1
10Light-induced expression of fatty acid desaturase genes显示文摘Kis M Zsiros O 1998Proc Natl Acad Sci USA1998,95,8:1
11The combination of intra- venous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian Cancer 显示文摘Barber EL Zsiros E Lurain JR 2013J GyneeoiOncol2013,24,3:1
12Light-induced expression of fatty acid desaturase genes显示文摘Kis M Zsiros O Farkas T 1998Proc Natl Acad Sei USA1998,95,8:1
13Isolation, Identification, and Characterization of a Novel, Oil-Degrading Bacterium, Pseudomonas aeruginosa T1 显示文摘Hasanuzzaman M Umadhay-Briones K M Zsiros S M 2004Curr Microblol2004,49,:1
14Developmental switch of the expression of ion channels in human dendritic ceils 显示文摘Zsiros E Kis-Toth K Hajdu P 2009J Immunol2009,183,7:1
15Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study 显示文摘Zsiros J Maibach R Shafford E 2010J Clin Oncol2010,28,15:1
16Learning multicriteria classification models from examples : decision rules in continuous space显示文摘Dombi J Zsiros A 2005European Journal of Operational Research2005,,3:1
17The combination of intrave- nous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer显示文摘Barber E L Zsiros E Lurain J R 2013J Gynecol Oncol2013,24,3:1
18Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study显示文摘Zsiros J Maibach R Shafford E 2010J Clin Oncol2010,28,15:1
19Dose-dense cisplatin- based chemotherapy and surgery for children with high-risk hepatoblastoma ( SIOPEL-4 ) : a prospective, single-arm, feasibility study显示文摘Zsiros J Brugieres L Brock P 2013Lancet Oncol2013,14,9:1
20Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma-a phase II trial of the childhood liver tumour strategy group (SIOPEL) 显示文摘Zsiros J Brugieres L Brock P 2012Eur J Cancer2012,48,18:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费